You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 258 No. 9, September 4, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fibrinogen and Risk of Cardiovascular Disease

The Framingham Study

William B. Kannel, MD; Philip A. Wolf, MD; William P. Castelli, MD; Ralph B. D'Agostino, PhD

JAMA. 1987;258(9):1183-1186.


Abstract

During the tenth biennial examination of the Framingham Study, 1315 participants who were free of cardiovascular disease had fibrinogen levels measured. During the ensuing 12 years, cardiovascular disease developed in 165 men and 147 women. For both sexes, the risk of cardiovascular disease was correlated positively to antecedent fibrinogen values higher than the 1.3 to 7.0 g/L (126 to 696 mg/dL) range. The magnitude of the risk diminished with advancing age in women but not in men. Risk for coronary heart disease also was significantly related to fibrinogen level. Here, the magnitude of risk displayed diminishing impact with age, again only in women. Risk of stroke increased progressively with fibrinogen level in men but not in women. The impact of fibrinogen value, considered as a separate variable, on cardiovascular disease was comparable with the major risk factors, such as blood pressure, hematocrit, adiposity, cigarette smoking, and diabetes. Fibrinogen values were also significantly related to these risk factors. Taking all these into account in a multivariate analysis, fibrinogen level was still significantly related to the incidence of cardiovascular disease in men and marginally significant in women. For coronary heart disease, the fibrinogen level was significant for both men and women. Elevated fibrinogen level is a predictor of cardiovascular disease that should be added to the cardiovascular risk factor profile.

(JAMA 1987;258:1183-1186)



Author Affiliations

From the Section of Preventive Medicine and Epidemiology (Dr Kannel) and the Department of Neurology (Dr Wolf), Boston University Medical Center; the National Heart, Lung, and Blood Institute, Framingham, Mass (Dr Castelli); and the Department of Mathematics, Boston University College of Liberal Arts (Dr D'Agostino).


Footnotes

Reprint requests to Section of Preventive Medicine and Epidemiology, Boston University Medical Center, Doctor's Office Building, Suite 1105, 720 Harrison Ave, Boston, MA 02118 (Dr Kannel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Annual variations in indoor climate in the homes of elderly persons living in Dublin, Ireland and Tromso, Norway
Bokenes et al.
Eur J Public Health 2009;0:ckp109v1-ckp109.
FULL TEXT  

Association of Novel Genetic Loci With Circulating Fibrinogen Levels: A Genome-Wide Association Study in 6 Population-Based Cohorts
Dehghan et al.
Circ Cardiovasc Genet 2009;2:125-133.
ABSTRACT | FULL TEXT  

Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women: The Women's Genome Health Study
Danik et al.
Circ Cardiovasc Genet 2009;2:134-141.
ABSTRACT | FULL TEXT  

Fibrinogen {beta}-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor
Parastatidis et al.
J. Biol. Chem. 2008;283:33846-33853.
ABSTRACT | FULL TEXT  

Coagulation Activity Before and After Acute Psychosocial Stress Increases With Age
Wirtz et al.
Psychosom. Med. 2008;70:476-481.
ABSTRACT | FULL TEXT  

High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans
Anuurad et al.
J. Clin. Endocrinol. Metab. 2008;93:1482-1488.
ABSTRACT | FULL TEXT  

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard and Libby
Clin. Chem. 2008;54:24-38.
ABSTRACT | FULL TEXT  

No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis
Zalewski et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2258-2265.
ABSTRACT | FULL TEXT  

Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I Deficient Mice
Parastatidis et al.
Circ. Res. 2007;101:368-376.
ABSTRACT | FULL TEXT  

The Effect of Urban Air Pollution on Inflammation, Oxidative Stress, Coagulation, and Autonomic Dysfunction in Young Adults
Chuang et al.
Am. J. Respir. Crit. Care Med. 2007;176:370-376.
ABSTRACT | FULL TEXT  

Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study
Atteritano et al.
J. Clin. Endocrinol. Metab. 2007;92:3068-3075.
ABSTRACT | FULL TEXT  

Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study
Aono et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:963-968.
ABSTRACT | FULL TEXT  

Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study
Sinning et al.
Eur Heart J 2006;27:2962-2968.
ABSTRACT | FULL TEXT  

Inflammatory Response After Influenza Vaccination in Men With and Without Carotid Artery Disease
Carty et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:2738-2744.
ABSTRACT | FULL TEXT  

Positive Association Between Plasma Fibrinogen Level and Incident Hypertension Among Men: Population-Based Cohort Study
Shankar et al.
Hypertension 2006;48:1043-1049.
ABSTRACT | FULL TEXT  

Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women
Ho et al.
Hum Reprod 2006;21:2715-2720.
ABSTRACT | FULL TEXT  

Plasma Fibrinogen Concentrations and Risk of Stroke and Its Subtypes Among Japanese Men and Women
Sato et al.
Stroke 2006;37:2488-2492.
ABSTRACT | FULL TEXT  

Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
Hartmann et al.
J Am Coll Cardiol 2006;48:446-452.
ABSTRACT | FULL TEXT  

Plasma fibrinogen and lung function: the CARDIA Study
Thyagarajan et al.
Int J Epidemiol 2006;35:1001-1008.
ABSTRACT | FULL TEXT  

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2006;114:381-387.
ABSTRACT | FULL TEXT  

Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Blankenberg et al.
Circulation 2006;114:201-208.
ABSTRACT | FULL TEXT  

Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis: The Edinburgh Artery Study
Tzoulaki et al.
Am J Epidemiol 2006;163:334-341.
ABSTRACT | FULL TEXT  

Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study
Smith et al.
Circulation 2005;112:3080-3087.
ABSTRACT | FULL TEXT  

What is the relationship between risk factor reduction and degree of weight loss?
Van Gaal et al.
Eur Heart J Suppl 2005;7:L21-L26.
ABSTRACT | FULL TEXT  

Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-analysis
Fibrinogen Studies Collaboration*
JAMA 2005;294:1799-1809.
ABSTRACT | FULL TEXT  

Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
Woodward et al.
Stroke 2005;36:2143-2147.
ABSTRACT | FULL TEXT  

Circulating Biomarkers in Acute Coronary Syndromes: Something Different or More of the Same?
Keaney
Circulation 2005;112:778-780.
FULL TEXT  

Prognostic Impact of Fibrinogen in Carotid Atherosclerosis: Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression?
Sabeti et al.
Stroke 2005;36:1400-1404.
ABSTRACT | FULL TEXT  

Inflammatory markers and cardiovascular health in older adults
Kritchevsky et al.
Cardiovasc Res 2005;66:265-275.
ABSTRACT | FULL TEXT  

Conditional Risk Factors for Atherosclerosis
Kullo and Ballantyne
Mayo Clin Proc. 2005;80:219-230.
ABSTRACT  

The - 148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study
van Goor et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:121-123.
ABSTRACT | FULL TEXT  

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of Inflammatory Markers to Predict Disease in Asymptomatic Patients: A Background Paper
Wilson
Circulation 2004;110:e568-e571.
ABSTRACT | FULL TEXT  

Morning levels of fibrinogen in children with sleep-disordered breathing
Kaditis et al.
Eur Respir J 2004;24:790-797.
ABSTRACT | FULL TEXT  

Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke
Rothwell et al.
Stroke 2004;35:2300-2305.
ABSTRACT | FULL TEXT  

Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis
Simeoni et al.
Eur Heart J 2004;25:1438-1446.
ABSTRACT | FULL TEXT  

Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis
Chapman et al.
Stroke 2004;35:1619-1624.
ABSTRACT | FULL TEXT  

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker et al.
Circulation 2004;109:IV-6-IV-19.
FULL TEXT  

Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk
Friso et al.
Am. J. Clin. Nutr. 2004;79:992-998.
ABSTRACT | FULL TEXT  

Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species
Vadseth et al.
J. Biol. Chem. 2004;279:8820-8826.
ABSTRACT | FULL TEXT  

Genetics of fibrin clot structure: a twin study
Dunn et al.
Blood 2004;103:1735-1740.
ABSTRACT | FULL TEXT  

Fibrinogen: biochemistry, epidemiology and determinants
Kamath and Lip
QJM 2003;96:711-729.
FULL TEXT  

Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
Jousilahti et al.
J. Epidemiol. Community Health 2003;57:730-733.
ABSTRACT | FULL TEXT  

The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis
Rajaram
Am. J. Clin. Nutr. 2003;78:552S-558.
ABSTRACT | FULL TEXT  

Thrombin, Inflammation, and Cardiovascular Disease: An Epidemiologic Perspective
Tracy
Chest 2003;124 :49S-57S.
ABSTRACT | FULL TEXT  

Fibrinogen - marker or mediator of vascular disease?
Reinhart
Vasc Med 2003;8:211-216.
ABSTRACT  

Increased Fibrin Polymerization Rate in Patients with Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
De Pablo et al.
CLIN APPL THROMB HEMOST 2003;9:221-225.
ABSTRACT  

Insulin Acutely Increases Fibrinogen Production in Individuals With Type 2 Diabetes but Not in Individuals Without Diabetes
Barazzoni et al.
Diabetes 2003;52:1851-1856.
ABSTRACT | FULL TEXT  

Improved Cardiovascular Risk Profile and Renal Function in Renal Transplant Patients after Randomized Conversion from Cyclosporine to Tacrolimus
Artz et al.
J. Am. Soc. Nephrol. 2003;14:1880-1888.
ABSTRACT | FULL TEXT  

Plant and Marine Derived (n-3) Polyunsaturated Fatty Acids Do Not Affect Blood Coagulation and Fibrinolytic Factors in Moderately Hyperlipidemic Humans
Finnegan et al.
J. Nutr. 2003;133:2210-2213.
ABSTRACT | FULL TEXT  

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study
Luc et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1255-1261.
ABSTRACT | FULL TEXT  

Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis
Klocke et al.
Ann Rheum Dis 2003;62:414-418.
ABSTRACT | FULL TEXT  

Smoking and the Risk of Hemorrhagic Stroke in Men
Kurth et al.
Stroke 2003;34:1151-1155.
ABSTRACT | FULL TEXT  

Hemostatic Effects of Atorvastatin Versus Simvastatin
Kadikoylu et al.
The Annals of Pharmacotherapy 2003;37:478-484.
ABSTRACT | FULL TEXT  

Fibrinogen Gene Promoter -455 A Allele as a Risk Factor for Lacunar Stroke
Martiskainen et al.
Stroke 2003;34:886-891.
ABSTRACT | FULL TEXT  

Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study
Kofoed et al.
Eur Heart J 2003;24:567-576.
ABSTRACT | FULL TEXT  

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson et al.
Circulation 2003;107:499-511.
FULL TEXT  

Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort
Tanne et al.
Stroke 2002;33:2182-2186.
ABSTRACT | FULL TEXT  

Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes
Al Suwaidi et al.
Circulation 2002;106:974-980.
ABSTRACT | FULL TEXT  

D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease
Komarov et al.
Eur Heart J 2002;23:1309-1316.
ABSTRACT  

The Value of Inflammation for Predicting Unstable Angina
Keaney and Vita
NEJM 2002;347:55-57.
FULL TEXT  

Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women
Braunstein et al.
Chest 2002;121:906-920.
ABSTRACT | FULL TEXT  

Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe
Bots et al.
J. Epidemiol. Community Health 2002;56:i14-18.
ABSTRACT | FULL TEXT  

Prosthetic valve thrombosis: predisposition and diagnosis
Piper et al.
Eur Heart J Suppl 2001;3:Q16-Q21.
ABSTRACT  

Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart
Marchioli et al.
Eur Heart J 2001;22:2085-2103.
ABSTRACT  

Acute Effect of Pegvisomant on Cardiovascular Risk Markers in Healthy Men: Implications for the Pathogenesis of Atherosclerosis in GH Deficiency
Muller et al.
J. Clin. Endocrinol. Metab. 2001;86:5165-5171.
ABSTRACT | FULL TEXT  

Fibrinogen and Preclinical Echocardiographic Target Organ Damage: The Strong Heart Study
Palmieri et al.
Hypertension 2001;38:1068-1074.
ABSTRACT | FULL TEXT  

Genetic aspects of the hemostatic system in cerebrovascular disease
Catto
Neurology 2001;57:S24-30.
ABSTRACT | FULL TEXT  

Effects of Psychological Stress and Psychiatric Disorders on Blood Coagulation and Fibrinolysis: A Biobehavioral Pathway to Coronary Artery Disease?
von Kanel et al.
Psychosom. Med. 2001;63:531-544.
ABSTRACT | FULL TEXT  

Sleep-Related Breathing Disorders and Risk of Stroke Editorial Comment : Balancing Sleep and Breathing
Mohsenin and Culebras
Stroke 2001;32:1271-1278.
ABSTRACT | FULL TEXT  

Genetics of Arterial Prothrombotic Risk States
Williams and Bray
Exp. Biol. Med. 2001;226:409-419.
ABSTRACT | FULL TEXT  

Insulin Resistance and Elevated Levels of Tissue Plasminogen Activator in First-Degree Relatives of South Asian Patients With Ischemic Cerebrovascular Disease
Kain et al.
Stroke 2001;32:1069-1073.
ABSTRACT | FULL TEXT  

Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke
Di Napoli et al.
Stroke 2001;32:133-138.
ABSTRACT | FULL TEXT  

Fibrinogen, Stroke, and Obstructive Sleep Apnea . An Evolving Paradigm of Cardiovascular Risk
Shamsuzzaman and Somers
Am. J. Respir. Crit. Care Med. 2000;162:2018-2020.
FULL TEXT  

Fibrinogen Levels and Obstructive Sleep Apnea in Ischemic Stroke
WESSENDORF et al.
Am. J. Respir. Crit. Care Med. 2000;162:2039-2042.
ABSTRACT | FULL TEXT  

Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance Syndrome
Sakkinen et al.
Am J Epidemiol 2000;152:897-907.
ABSTRACT | FULL TEXT  

Age, Functional Status, and Racial Differences in Plasma D-Dimer Levels in Community-Dwelling Elderly Persons
Pieper et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2000;55:649M-657.
ABSTRACT | FULL TEXT  

Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population
Stec et al.
Circulation 2000;102:1634-1638.
ABSTRACT | FULL TEXT  

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6
Woods et al.
Eur Heart J 2000;21:1574-1583.
 

C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men
Garcia-Moll et al.
Eur Heart J 2000;21:1598-1606.
ABSTRACT  

Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
Van de Water et al.
J Am Coll Cardiol 2000;36:717-722.
ABSTRACT | FULL TEXT  

Increased Fibrinogen Production in Type 2 Diabetic Patients without Detectable Vascular Complications: Correlation with Plasma Glucagon Concentrations
Barazzoni et al.
J. Clin. Endocrinol. Metab. 2000;85:3121-3125.
ABSTRACT | FULL TEXT  

Inverse Association of Physical Fitness with Plasma Fibrinogen Level in Children The Columbia University BioMarkers Study
Isasi et al.
Am J Epidemiol 2000;152:212-218.
ABSTRACT | FULL TEXT  

The thyroid, blood flow and atheroma
Fowler
QJM 2000;93:477-485.
FULL TEXT  

Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm
Sadanandan and Sherrid
J Am Coll Cardiol 2000;35:1932-1938.
ABSTRACT | FULL TEXT  

Ancrod--Is Snake Venom an Antidote for Stroke?
Mayberg and Furlan
JAMA 2000;283:2440-2442.
FULL TEXT  

Inflammation-mediated rheumatic diseases and atherosclerosis
MANZI et al.
Ann Rheum Dis 2000;59:321-325.
FULL TEXT  

Systemic lupus erythematosus: a model for atherogenesis?
Manzi
Rheumatology (Oxford) 2000;39:353-359.
FULL TEXT  

International differences: selection, noise, or real?
White
Eur Heart J 2000;21:339-342.
 

Cardiovascular risk in women: the cardiologist's perspective
EDMUNDS and LIP
QJM 2000;93:135-145.
FULL TEXT  

Hyperfibrinogenemia Is Associated With Specific Histocytological Composition and Complications of Atherosclerotic Carotid Plaques in Patients Affected by Transient Ischemic Attacks
Mauriello et al.
Circulation 2000;101:744-750.
ABSTRACT | FULL TEXT  

Determinants of Population Changes in Fibrinogen and Factor VII Over 6 Years : The Atherosclerosis Risk in Communities (ARIC) Study
Folsom et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:601-606.
ABSTRACT | FULL TEXT  

Differential hepatic lobar gene expression in offspring exposed to altered maternal dietary protein intake
Zhang and Byrne
Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G128-G136.
ABSTRACT | FULL TEXT  

Two Common, Functional Polymorphisms in the Promoter Region of the {beta}-Fibrinogen Gene Contribute to Regulation of Plasma Fibrinogen Concentration
van ’t Hooft et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:3063-3070.
ABSTRACT | FULL TEXT  

Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries
Erren et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:2355-2363.
ABSTRACT | FULL TEXT  

Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Harjai
ANN INTERN MED 1999;131:376-386.
ABSTRACT | FULL TEXT  

Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia
Pfefferkorn et al.
Stroke 1999;30 :e1802-1806.
ABSTRACT | FULL TEXT  

Prospective Study of Markers of Hemostatic Function With Risk of Ischemic Stroke
Folsom et al.
Circulation 1999;100:736-742.
ABSTRACT | FULL TEXT  

The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly : Results From the Cardiovascular Health Study
Tracy et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:1776-1783.
ABSTRACT | FULL TEXT  

Effects of physical training and its cessation on the hemostatic system of obese children
Ferguson et al.
Am. J. Clin. Nutr. 1999;69:1130-1134.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.